273.60

0.54% 1.48

After Hours: 273.60

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $273.60, with a volume of 252.44K. It is up +0.54% in the last 24 hours and up +1.46% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$272.12

Open:

$273.92

24h Volume:

252.44K

Relative Volume:

0.95

Market Cap:

$7.38B

Revenue:

$2.58B

Net Income/Loss:

$759.90M

P/E Ratio:

9.8006

EPS:

27.9168

Net Cash Flow:

$374.60M

1W Performance:

+2.09%

1M Performance:

+1.46%

6M Performance:

+1.18%

1Y Performance:

+10.63%

1-Day Range:

$269.10

$276.13

1-Week Range:

$260.58

$276.13

52-Week Range:

$211.43

$343.12

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,450

Twitter

@BioRadLifeSci

Next Earnings Date

2024-10-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	273.60	7.34B	2.58B	759.90M	374.60M	27.92
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

Mar 24, 2026

Biosensors Market Is Going to BoomKey Factors Driving - openPR.com

Mar 24, 2026

Enzyme Linked Immunosorbent Assay Market Future Business - openPR.com

Mar 24, 2026

Mar 21, 2026

Retail Trends: What is the long term forecast for Bio Rad Laboratories Inc. stock2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 20, 2026

Bio-Rad Laboratories Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo

Mar 20, 2026

Disappointing Results Hurt Bio-Rad Laboratories (BIO) - Insider Monkey

Mar 20, 2026

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.

Mar 20, 2026

Mar 18, 2026

Moving Averages: Is Bio Rad Laboratories Inc likely to announce a buybackWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn

Mar 18, 2026

Moore Capital Management LP Acquires Shares of 55,000 Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 17, 2026

Gotham Asset Management LLC Acquires 36,763 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 17, 2026

Mar 16, 2026

Hound Partners LLC Has $29.15 Million Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 16, 2026

Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Mar 16, 2026

Mar 14, 2026

Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 14, 2026

Perbak Capital Partners LLP Purchases 5,423 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 14, 2026

Portolan Capital Management LLC Has $13.02 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Mar 14, 2026

Mar 12, 2026

10,425 Shares in Bio-Rad Laboratories, Inc. $BIO Purchased by Magnetar Financial LLC - MarketBeat

Mar 12, 2026